U.S. flag

An official website of the United States government

NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup) AND BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 1, 2005
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000005127.3

Allele description [Variation Report for NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)]

NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)

Gene:
FOXL2:forkhead box L2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
3q22.3
Genomic location:
Preferred name:
NM_023067.4(FOXL2):c.672_701dup (p.Ala225_Ala234dup)
HGVS:
  • NC_000003.12:g.138946030_138946059dup
  • NG_012454.1:g.6090_6119dup
  • NG_029796.1:g.3797_3826dup
  • NM_023067.4:c.672_701dupMANE SELECT
  • NP_075555.1:p.Ala225_Ala234dup
  • LRG_1295t1:c.672_701dup
  • LRG_1295:g.6090_6119dup
  • LRG_1295p1:p.Ala225_Ala234dup
  • NC_000003.11:g.138664863_138664864insGCGGCTGCAGCCGCAGCTGCTGCAGCCGCT
  • NC_000003.11:g.138664872_138664901dup
  • NM_023067.3:c.672_701dup30
  • p.(Ala225_Ala234dup)
  • p.[Ala225_Ala234dup]
Links:
OMIM: 605597.0002; dbSNP: rs387906321
NCBI 1000 Genomes Browser:
rs387906321
Molecular consequence:
  • NM_023067.4:c.672_701dup - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Name:
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS, TYPE II (BPES II)
Synonyms:
Blepharophimosis syndrome type 2; BPES type 2; Blepharophimosis, ptosis, and epicanthus inversus type 2; See all synonyms [MedGen]
Identifiers:
MedGen: C2931136

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000025304OMIM
no assertion criteria provided
Pathogenic
(Dec 1, 2005)
germlineliterature only

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.

Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G.

Nat Genet. 2001 Feb;27(2):159-66.

PubMed [citation]
PMID:
11175783

Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families.

Ramírez-Castro JL, Pineda-Trujillo N, Valencia AV, Muñetón CM, Botero O, Trujillo O, Vásquez G, Mora BE, Durango N, Bedoya G, Ruiz-Linares A.

Am J Med Genet. 2002 Nov 15;113(1):47-51.

PubMed [citation]
PMID:
12400065
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000025304.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (4)

Description

In affected members of 2 families with BPES type II (110100), and in a sporadic male BPES patient, Crisponi et al. (2001) identified a 30-bp duplication at position 909 to 938. Amino acids 224 to 234 were duplicated. In the 2 families with multiple cases, affected females transmitted the trait to the next generation.

Ramirez-Castro et al. (2002) identified this mutation in affected members of 2 families with BPES type II from a historically isolated population in northwest Colombia. The genotype/phenotype correlation in the families was consistent with a proposal that BPES type I is caused by truncating mutations leading to haploinsufficiency, while BPES type II is caused by mutations generating elongated protein products (see also 605597.0008). This duplication has also been described as recurrent in unrelated familial and sporadic BPES cases in Europe; its recurrence may be related to the secondary structure of the particular DNA region.

In both a family and sporadic case of BPES type II from Algeria, Dollfus et al. (2003) identified this mutation.

In an 18-month-old girl with sporadic BPES and bilateral type 1 Duane syndrome (see 126800), Vincent et al. (2005) identified heterozygosity for a 30-bp duplication, which they designated 672_701dup30 based on numbering from the ATG start codon, resulting in a duplication of 10 alanine residues at codon 224 in the FOXL2 gene.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024